Edwin Chapman

Education:

B.S. Chemistry and Biology, Western Washington University, Bellingham, WA

Ph.D., Dept. of Pharmacology, University of Washington, Seattle, WA

Hobbies/Interests: Hi-Fi and Films

Relevant Web Links:

• HHMI webpage

• UW Neuroscience webpage

Curriculm Vitae

Research Experience

1985-1987    Research technician II. Genetic Systems Inc., Seattle WA.

1987-1992    Ph.D. thesis research.  Advisor:  Dr. Dan Storm, Dept of Pharmacology, University of Washington.

1992-1996    Post-doctoral Fellow. Sponsor: Dr. Reinhard Jahn, Howard Hughes Medical Institute, Yale University.

1996-2001    Assistant Professor. Dept. of Physiology, University of Wisconsin.

2001-2005    Associate Professor, Dept. of Physiology, University of Wisconsin.

2005-present    Professor, Dept. of Neuroscience, University of Wisconsin.

2005-present    Investigator, Howard Hughes Medical Institute.

Fellowships, Honors, Awards

1992-1996    Howard Hughes Post-doctoral Associate, Yale U.

1996    U. of Wisconsin/Howard Hughes Medical Institute Career Development Award; U. of Wisconsin/Howard Hughes Medical Institute Infomatics Award; Hilldale, UW-Bookstore, and HHMI Awards (undergraduate)

1998    Shaw Scientists Award

1999    Dave McClain American Heart Research Award

1999    Pew Scholars Award

2003-present    Rose Awards (to J.B in 2003, M.D. in 2004, M.C. in 2008, E.H. in 2009, S.E.K. in 2012, H.B. in 2015, C.S.E. in 2016, E.B.W. in  2018); for outstanding thesis in the neurosciences

2004    H. I. Romnes Faculty Fellow Award

2006-present    Member, Faculty of 1000

2011    Kellet Mid-Career Award

2018-present    Ricardo Miledi Professor of Neuroscience (endowed professorship)

2018-present    Director of the Quantitative Membrane Biophysics Program

2019    Receipient of the Sir Bernard Katz Award, Exocytosis/Endocytosis subgroup of the Biophysical Society

Patents

E.R. Chapman and M. Dong, 2011, “Botulinum Neurotoxin B Receptors and Uses Thereof”, Issued US Patent 8617573

E.R. Chapman and M. Dong, 2015, “Method and Compositions for Detecting Botulinum Neurotoxin”, US Patent Application No. 14/624775

E.R. Chapman and M. Dong, 2012, “Method and Compositions for Detecting Botulinum Neurotoxin”, Issued US Patent 8987208

E.R. Chapman and M. Dong, 2004, “Method and Compositions for Detecting Botulinum Neurotoxin”, Issued US Patent No. 8137924

E.R. Chapman and Min Dong, 2013 “Botulinum Neurotoxin A Receptor and the use Thereof”, Issue US Patent No. 8987208

E.R. Chapman and M. Dong, 2011 “Botulinum Neurotoxin A Receptor and the use Thereof”, Issued US Patent No. 8450277

E.R. Chapman and M. Dong, 2006 “Botulinum Neurotoxin A Receptor and the use Thereof”, Issued US Patent No. 7985554

E.R. Chapman and M. Don, 2014 “Botulinum Neurotoxin E Receptor and the use Thereof”, US Patent Application No. 14/282709

E.R. Chapman and M. Dong, 2009 “Botulinum Neurotoxin E Receptor and the use Thereof”, Issued US Patent No. 8771707

E.R. Chapman and F. Yeh, 2012 ” Method for Selective Targeting and Entry of Bacterial Toxins to Cells”, Issued US Patent No. 9623117

Companies

Part owner of BioSentinel, Inc. (a local company that was formed based on the patents listed above)